000 01381 a2200397 4500
005 20250515080250.0
264 0 _c20070830
008 200708s 0 0 eng d
022 _a1873-4286
024 7 _a10.2174/138161207781368738
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFrigeri, Antonio
245 0 0 _aAquaporins as targets for drug discovery.
_h[electronic resource]
260 _bCurrent pharmaceutical design
_c2007
300 _a2421-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAquaporins
_xdrug effects
650 0 4 _aBrain
_xdrug effects
650 0 4 _aDrug Design
650 0 4 _aDrug Evaluation, Preclinical
_xmethods
650 0 4 _aEye
_xdrug effects
650 0 4 _aHumans
650 0 4 _aKidney
_xdrug effects
650 0 4 _aMembrane Transport Modulators
_xchemistry
650 0 4 _aNeoplasms
_xmetabolism
650 0 4 _aObesity
_xmetabolism
650 0 4 _aSalivary Glands
_xdrug effects
650 0 4 _aSkin
_xdrug effects
650 0 4 _aWater
_xmetabolism
650 0 4 _aWater-Electrolyte Balance
_xdrug effects
700 1 _aNicchia, Grazia Paola
700 1 _aSvelto, Maria
773 0 _tCurrent pharmaceutical design
_gvol. 13
_gno. 23
_gp. 2421-7
856 4 0 _uhttps://doi.org/10.2174/138161207781368738
_zAvailable from publisher's website
999 _c17223758
_d17223758